STOCKWATCH
·
Pharmaceuticals
Quarterly Result13 Nov 2025, 03:32 pm

Denis Chem Lab Ltd Announces Q3 2025 Unaudited Financial Results with a 6.25% YoY Revenue Growth

AI Summary

Denis Chem Lab Ltd, a leading manufacturer of parenteral products, announced its unaudited financial results for the quarter ended on 30th September, 2025. The company recorded a revenue from operations of Rs. 4,617.13 lakh, representing a 6.25% year-over-year growth compared to the same quarter in the previous year. Total income stood at Rs. 4,681.82 lakh, with a profit before tax of Rs. 470.58 lakh. The company's earnings per share (EPS) for continuing operations were Rs. 2.54.

Key Highlights

  • Revenue from operations for Q3 2025 stood at Rs. 4,617.13 lakh, a 6.25% YoY growth.
  • Total income for Q3 2025 was Rs. 4,681.82 lakh.
  • Profit before tax for Q3 2025 amounted to Rs. 470.58 lakh.
  • EPS for continuing operations in Q3 2025 was Rs. 2.54.
DENISCHEM
Pharmaceuticals
Denis Chem Lab Ltd

Price Impact